253 related articles for article (PubMed ID: 36728430)
1. Mouse-Adapted SARS-CoV-2 MA10 Strain Displays Differential Pulmonary Tropism and Accelerated Viral Replication, Neurodissemination, and Pulmonary Host Responses in K18-hACE2 Mice.
Thieulent CJ; Dittmar W; Balasuriya UBR; Crossland NA; Wen X; Richt JA; Carossino M
mSphere; 2023 Feb; 8(1):e0055822. PubMed ID: 36728430
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
Winkler ES; Chen RE; Alam F; Yildiz S; Case JB; Uccellini MB; Holtzman MJ; Garcia-Sastre A; Schotsaert M; Diamond MS
J Virol; 2022 Jan; 96(1):e0151121. PubMed ID: 34668780
[TBL] [Abstract][Full Text] [Related]
3. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
[TBL] [Abstract][Full Text] [Related]
4. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
[TBL] [Abstract][Full Text] [Related]
5. Microglia Do Not Restrict SARS-CoV-2 Replication following Infection of the Central Nervous System of K18-Human ACE2 Transgenic Mice.
Olivarria GM; Cheng Y; Furman S; Pachow C; Hohsfield LA; Smith-Geater C; Miramontes R; Wu J; Burns MS; Tsourmas KI; Stocksdale J; Manlapaz C; Yong WH; Teijaro J; Edwards R; Green KN; Thompson LM; Lane TE
J Virol; 2022 Feb; 96(4):e0196921. PubMed ID: 34935438
[TBL] [Abstract][Full Text] [Related]
6. Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.
Kim SH; Kim J; Jang JY; Noh H; Park J; Jeong H; Jeon D; Uhm C; Oh H; Cho K; Jeon Y; On D; Yoon S; Lim SY; Kim SP; Lee YW; Jang HJ; Park IH; Oh J; Seo JS; Kim JJ; Seok SH; Lee YJ; Hong SM; An SH; Kim SY; Kim YB; Hwang JY; Lee HJ; Kim HB; Choi KS; Park JW; Seo JY; Yun JW; Shin JS; Lee HY; Kim K; Lee D; Lee H; Nam KT; Seong JK
Front Immunol; 2022; 13():1055811. PubMed ID: 36457995
[TBL] [Abstract][Full Text] [Related]
7. Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection.
Rathnasinghe R; Strohmeier S; Amanat F; Gillespie VL; Krammer F; García-Sastre A; Coughlan L; Schotsaert M; Uccellini MB
Emerg Microbes Infect; 2020 Dec; 9(1):2433-2445. PubMed ID: 33073694
[TBL] [Abstract][Full Text] [Related]
8. Fatal Neurodissemination and SARS-CoV-2 Tropism in K18-hACE2 Mice Is Only Partially Dependent on hACE2 Expression.
Carossino M; Kenney D; O'Connell AK; Montanaro P; Tseng AE; Gertje HP; Grosz KA; Ericsson M; Huber BR; Kurnick SA; Subramaniam S; Kirkland TA; Walker JR; Francis KP; Klose AD; Paragas N; Bosmann M; Saeed M; Balasuriya UBR; Douam F; Crossland NA
Viruses; 2022 Mar; 14(3):. PubMed ID: 35336942
[TBL] [Abstract][Full Text] [Related]
9. Human convalescent plasma protects K18-hACE2 mice against severe respiratory disease.
Golden JW; Zeng X; Cline CR; Garrison AR; White LE; Fitzpatrick CJ; Kwilas SA; Bowling PA; Fiallos JO; Moore JL; Sifford WB; Ricks KM; Mucker EM; Smith JM; Hooper JW
J Gen Virol; 2021 May; 102(5):. PubMed ID: 33961540
[TBL] [Abstract][Full Text] [Related]
10. Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2.
Golden JW; Li R; Cline CR; Zeng X; Mucker EM; Fuentes-Lao AJ; Spik KW; Williams JA; Twenhafel N; Davis N; Moore JL; Stevens S; Blue E; Garrison AR; Larson DD; Stewart R; Kunzler M; Liu Y; Wang Z; Hooper JW
mBio; 2022 Feb; 13(1):e0290621. PubMed ID: 35073750
[TBL] [Abstract][Full Text] [Related]
11. The lethal K18-hACE2 knock-in mouse model mimicking the severe pneumonia of COVID-19 is practicable for antiviral development.
Zhang Z; Zhou L; Liu Q; Zheng Y; Tan X; Huang Z; Guo M; Wang X; Chen X; Liang S; Li W; Song K; Yan K; Li J; Li Q; Zhang Y; Yang S; Cai Z; Dai M; Xian Q; Shi ZL; Xu K; Lan K; Chen Y
Emerg Microbes Infect; 2024 Dec; 13(1):2353302. PubMed ID: 38753462
[TBL] [Abstract][Full Text] [Related]
12. Development of transgenic models susceptible and resistant to SARS-CoV-2 infection in FVB background mice.
Seo SM; Son JH; Lee JH; Kim NW; Yoo ES; Kang AR; Jang JY; On DI; Noh HA; Yun JW; Park JW; Choi KS; Lee HY; Shin JS; Seo JY; Nam KT; Lee H; Seong JK; Choi YK
PLoS One; 2022; 17(7):e0272019. PubMed ID: 35881617
[TBL] [Abstract][Full Text] [Related]
13. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
Li K; Meyerholz DK; Bartlett JA; McCray PB
mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
[TBL] [Abstract][Full Text] [Related]
14. The Delta SARS-CoV-2 Variant of Concern Induces Distinct Pathogenic Patterns of Respiratory Disease in K18-hACE2 Transgenic Mice Compared to the Ancestral Strain from Wuhan.
Liu X; Mostafavi H; Ng WH; Freitas JR; King NJC; Zaid A; Taylor A; Mahalingam S
mBio; 2022 Jun; 13(3):e0068322. PubMed ID: 35420469
[TBL] [Abstract][Full Text] [Related]
15. Animal Models of COVID-19: Transgenic Mouse Model.
Park JG; Pino PA; Akhter A; Alvarez X; Torrelles JB; Martinez-Sobrido L
Methods Mol Biol; 2022; 2452():259-289. PubMed ID: 35554912
[TBL] [Abstract][Full Text] [Related]
16. Differential Pathogenesis of SARS-CoV-2 Variants of Concern in Human ACE2-Expressing Mice.
Natekar JP; Pathak H; Stone S; Kumari P; Sharma S; Auroni TT; Arora K; Rothan HA; Kumar M
Viruses; 2022 May; 14(6):. PubMed ID: 35746611
[TBL] [Abstract][Full Text] [Related]
17. Differential Outcomes of Infection by Wild-Type SARS-CoV-2 and the B.1.617.2 and B.1.1.529 Variants of Concern in K18-hACE2 Transgenic Mice.
He Y; Henley J; Sell P; Comai L
Viruses; 2023 Dec; 16(1):. PubMed ID: 38257760
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 Infects Primary Neurons from Human ACE2 Expressing Mice and Upregulates Genes Involved in the Inflammatory and Necroptotic Pathways.
Rothan HA; Kumari P; Stone S; Natekar JP; Arora K; Auroni TT; Kumar M
Pathogens; 2022 Feb; 11(2):. PubMed ID: 35215199
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 strains bearing Omicron BA.1 spike replicate in C57BL/6 mice.
Ogger PP; Martín MG; Jang S; Zhou J; Brown J; Sukhova K; Furnon W; Patel AH; Cowton V; Palmarini M; Barclay WS; Johansson C
Front Immunol; 2024; 15():1383612. PubMed ID: 38742107
[TBL] [Abstract][Full Text] [Related]
20. Evaluating Antibody Mediated Protection against Alpha, Beta, and Delta SARS-CoV-2 Variants of Concern in K18-hACE2 Transgenic Mice.
Wong TY; Horspool AM; Russ BP; Ye C; Lee KS; Winters MT; Bevere JR; Miller OA; Rader NA; Cooper M; Kieffer T; Sourimant J; Greninger AL; Plemper RK; Denvir J; Cyphert HA; Barbier M; Torrelles JB; Martinez I; Martinez-Sobrido L; Damron FH
J Virol; 2022 Mar; 96(6):e0218421. PubMed ID: 35080423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
